Lisata Therapeutics LSTA
NASDAQ LSTA
$1.47 -0.03 (-2.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Share-based Compensation (2010 - 2026)

Updated

Lisata Therapeutics (LSTA) reported Share-based Compensation of $214,000 for Q2 2026, down 10.5% from $239,000 a year earlier and down 41.2% from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lisata Therapeutics' Share-based Compensation came in at $1.04 million, down 40.2% year-over-year; for FY2025, it was $1.23 million, down 25.8% from FY2024.

  • Share-based Compensation has declined for three consecutive years, with a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $1.65 million in FY2024 (-18.9%), $2.04 million in FY2023 (-22.7%), $2.64 million in FY2022 (+31.5%) and $2.01 million in FY2021 (+58.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q4 2020.
  • Year over year, Share-based Compensation has now declined in each of the last four quarters, with an average decline of 9.6% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 237.1%); the low point was Q3 2023 (a decline of 70.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $364,000 (Q1 2026), $225,000 (Q4 2025) and $232,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Lisata Therapeutics 13.68 Mn 13.42 Mn - 214,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214,000.00
Mar 31, 2026 364,000.00
Dec 31, 2025 225,000.00
Sep 30, 2025 232,000.00
Jun 30, 2025 239,000.00
Mar 31, 2025 530,000.00
Dec 31, 2024 635,000.00
Sep 30, 2024 327,000.00
Jun 30, 2024 237,000.00
Mar 31, 2024 454,000.00
Dec 31, 2023 473,000.00
Sep 30, 2023 307,000.00
Jun 30, 2023 583,000.00
Mar 31, 2023 675,000.00
Dec 31, 2022 468,000.00
Sep 30, 2022 1.04 Mn
Jun 30, 2022 368,000.00
Mar 31, 2022 760,000.00
Dec 31, 2021 366,000.00
Sep 30, 2021 772,000.00
API Access

Lisata Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LSTA&period=max&api_key=YOUR_API_KEY